
Philips announces collaboration with Epic to enhance ambulatory cardiac monitoring
Philips will now offer the largest cardiac care portfolio through Epic's Aura platform
CAMBRIDGE, Mass. –
Royal Philips
(NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with
Epic
to integrate Philips' suite of cardiac ambulatory monitoring and diagnostics services with Aura, the specialty diagnostics suite of the leading electronic health record (EHR) company. This collaboration will offer the broadest cardiac care portfolio of any single service provider integrating with Aura to date. Philips will deliver a new level of interoperability between its ambulatory monitoring technologies and Epic—helping providers enhance the diagnostic process and improve patient outcomes.
With Philips' technology available through Aura, health system IT teams could significantly reduce the time it takes to connect with Philips [1] and give interested provider organizations the ability to order and review patients' ECG results directly in Epic. This cuts out the need for manual order and data entry, which enhances workflows for providers and streamlines data-driven care decisions.
'With this collaboration, we are advancing cardiac care in a way that simultaneously improves the clinician and patient experience,' said Stefano Folli, Business Leader, Ambulatory Monitoring & Diagnostics, Philips. 'Together, Philips and Epic can help enable workflow efficiencies that lighten cardiac care teams' load, so they can spend more time focusing on what matters most – providing direct patient care.'
The Philips-Epic collaboration can also streamline cumbersome administrative tasks by automating patient activation, staff notifications, and charting – giving valuable time back to cardiology teams to spend with patients.
'When a physician prescribes a cardiac monitor, it allows patients to be evaluated for heart conditions as they go about their daily lives, even before they see a cardiologist,' said Leah Johnson, vice president of cardiology and imaging diagnostics, Epic. 'Through this collaboration, we're streamlining the clinical experience for both patients and physicians, reducing administrative overhead and ensuring that detailed diagnostic reports are readily available in the patient's comprehensive health record.'
The Philips ambulatory monitoring portfolio features flexible remote monitoring and enterprise ECG management solutions designed to advance a new standard of cardiac care. By arming healthcare organizations with data and actionable insights that can transform workflows to diagnose and manage patient populations proactively, Philips' products and services help enable care delivery in the right setting, at the right time.
[1] See, for example, American Society of Clinical Oncology. (2024). [Abstract 416274]. ASCO regarding Aura time savings on connections to external pathology laboratories.
https://www.asco.org/abstracts-presentations/ABSTRACT416274
For further information, please contact:
Allison Johnson
Director, Monitoring Communications
Tel: +1 617-631-7305
E-mail:
allison.johnson@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at
www.philips.com/newscenter
.
Attachment

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
HubSpot (NYSE:HUBS) Beats Q2 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations
Sales and marketing software maker HubSpot (NYSE:HUBS) announced better-than-expected revenue in Q2 CY2025, with sales up 19.4% year on year to $760.9 million. Guidance for next quarter's revenue was better than expected at $786 million at the midpoint, 1.4% above analysts' estimates. Its non-GAAP profit of $2.19 per share was 3.1% above analysts' consensus estimates. Is now the time to buy HubSpot? Find out in our full research report. HubSpot (HUBS) Q2 CY2025 Highlights: Revenue: $760.9 million vs analyst estimates of $739.3 million (19.4% year-on-year growth, 2.9% beat) Adjusted EPS: $2.19 vs analyst estimates of $2.12 (3.1% beat) Adjusted Operating Income: $129.1 million vs analyst estimates of $124.9 million (17% margin, 3.4% beat) The company lifted its revenue guidance for the full year to $3.08 billion at the midpoint from $3.04 billion, a 1.4% increase Management raised its full-year Adjusted EPS guidance to $9.50 at the midpoint, a 1.8% increase Operating Margin: -3.2%, in line with the same quarter last year Free Cash Flow Margin: 15.3%, down from 16.5% in the previous quarter Customers: 267,982, up from 258,258 in the previous quarter Billings: $785.3 million at quarter end, up 21.2% year on year Market Capitalization: $25.96 billion 'Q2 was another solid quarter of continued revenue growth and customer expansion,' said Yamini Rangan, Chief Executive Officer at HubSpot. Company Overview Started in 2006 by two MIT grad students, HubSpot (NYSE:HUBS) is a software-as-a-service platform that helps small and medium-sized businesses market themselves, sell, and get found on the internet. Revenue Growth Reviewing a company's long-term sales performance reveals insights into its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last three years, HubSpot grew its sales at a decent 23.1% compounded annual growth rate. Its growth was slightly above the average software company and shows its offerings resonate with customers. This quarter, HubSpot reported year-on-year revenue growth of 19.4%, and its $760.9 million of revenue exceeded Wall Street's estimates by 2.9%. Company management is currently guiding for a 17.4% year-on-year increase in sales next quarter. Looking further ahead, sell-side analysts expect revenue to grow 14.9% over the next 12 months, a deceleration versus the last three years. Despite the slowdown, this projection is healthy and implies the market is baking in success for its products and services. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. Click here to access our free report one of our favorites growth stories. Billings Billings is a non-GAAP metric that is often called 'cash revenue' because it shows how much money the company has collected from customers in a certain period. This is different from revenue, which must be recognized in pieces over the length of a contract. HubSpot's billings punched in at $785.3 million in Q2, and over the last four quarters, its growth was impressive as it averaged 20.1% year-on-year increases. This performance aligned with its total sales growth, indicating robust customer demand. The high level of cash collected from customers also enhances liquidity and provides a solid foundation for future investments and growth. Customer Base HubSpot reported 267,982 customers at the end of the quarter, a sequential increase of 9,724. That's roughly in line with what we've observed over the last year, confirming that the company is maintaining its sales momentum. Key Takeaways from HubSpot's Q2 Results We enjoyed seeing HubSpot beat analysts' billings expectations this quarter. We were also glad its full-year EPS guidance slightly exceeded Wall Street's estimates. Overall, we think this was a decent quarter with some key metrics above expectations. The stock traded up 4.4% to $512 immediately following the results. HubSpot put up rock-solid earnings, but one quarter doesn't necessarily make the stock a buy. Let's see if this is a good investment. We think that the latest quarter is just one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
DoorDash (NASDAQ:DASH) Posts Better-Than-Expected Sales In Q2, Increases Its Orders
On-demand food delivery service DoorDash (NYSE:DASH) beat Wall Street's revenue expectations in Q2 CY2025, with sales up 24.9% year on year to $3.28 billion. Its GAAP profit of $0.65 per share was 49.5% above analysts' consensus estimates. Is now the time to buy DoorDash? Find out in our full research report. DoorDash (DASH) Q2 CY2025 Highlights: Revenue: $3.28 billion vs analyst estimates of $3.16 billion (24.9% year-on-year growth, 3.8% beat) EPS (GAAP): $0.65 vs analyst estimates of $0.43 (49.5% beat) Adjusted EBITDA: $655 million vs analyst estimates of $639.8 million (19.9% margin, 2.4% beat) EBITDA guidance for Q3 CY2025 is $730 million at the midpoint, above analyst estimates of $716.1 million Operating Margin: 5%, up from -7.6% in the same quarter last year Free Cash Flow Margin: 52.2%, up from 16.3% in the previous quarter Orders: 761 million, up 126 million year on year Market Capitalization: $108.2 billion Company Overview Founded by Stanford students with the intent to build 'the local, on-demand FedEx", DoorDash (NYSE:DASH) operates an on-demand food delivery platform. Revenue Growth A company's long-term performance is an indicator of its overall quality. Any business can have short-term success, but a top-tier one grows for years. Thankfully, DoorDash's 28.2% annualized revenue growth over the last three years was exceptional. Its growth surpassed the average consumer internet company and shows its offerings resonate with customers, a great starting point for our analysis. This quarter, DoorDash reported robust year-on-year revenue growth of 24.9%, and its $3.28 billion of revenue topped Wall Street estimates by 3.8%. Looking ahead, sell-side analysts expect revenue to grow 18.9% over the next 12 months, a deceleration versus the last three years. We still think its growth trajectory is attractive given its scale and indicates the market is forecasting success for its products and services. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Orders Request Growth As a gig economy marketplace, DoorDash generates revenue growth by expanding the number of services on its platform (e.g. rides, deliveries, freelance jobs) and raising the commission fee from each service provided. Over the last two years, DoorDash's orders, a key performance metric for the company, increased by 20.3% annually to 761 million in the latest quarter. This growth rate is among the fastest of any consumer internet business and indicates its offerings have significant traction. In Q2, DoorDash added 126 million orders, leading to 19.8% year-on-year growth. The quarterly print isn't too different from its two-year result, suggesting its new initiatives aren't accelerating request growth just yet. Revenue Per Request Average revenue per request (ARPR) is a critical metric to track because it measures how much the company earns in transaction fees from each request. This number also informs us about DoorDash's take rate, which represents its pricing leverage over the ecosystem, or "cut" from each transaction. DoorDash's ARPR growth has been mediocre over the last two years, averaging 3.5%. This isn't great, but the increase in orders is more relevant for assessing long-term business potential. We'll monitor the situation closely; if DoorDash tries boosting ARPR by taking a more aggressive approach to monetization, it's unclear whether requests can continue growing at the current pace. This quarter, DoorDash's ARPR clocked in at $4.32. It grew by 4.2% year on year, slower than its request growth. Key Takeaways from DoorDash's Q2 Results It was great to see DoorDash increase its number of requests this quarter. We were also happy its revenue outperformed Wall Street's estimates. Overall, this print had some key positives. The stock traded up 4.8% to $270.50 immediately following the results. Sure, DoorDash had a solid quarter, but if we look at the bigger picture, is this stock a buy? When making that decision, it's important to consider its valuation, business qualities, as well as what has happened in the latest quarter. We cover that in our actionable full research report which you can read here, it's free.
Yahoo
43 minutes ago
- Yahoo
First Eagle Investment's Strategic Moves: Spotlight on Becton Dickinson & Co
Analyzing the Latest 13F Filing for Q2 2025 First Eagle Investment (Trades, Portfolio) recently submitted its 13F filing for the second quarter of 2025, offering a glimpse into its strategic investment decisions. Established in 1864, First Eagle is a renowned independent investment management firm known for its value-oriented approach. The firm emphasizes long-term performance over short-term market fluctuations, employing rigorous bottom-up fundamental analysis to mitigate risk. First Eagle's strategy involves on-site research and direct engagement with company management to gain comprehensive insights into investment opportunities. The firm focuses on acquiring securities with intrinsic value and long-term potential that outweigh market risks. Warning! GuruFocus has detected 6 Warning Sign with META. Summary of New Buy First Eagle Investment (Trades, Portfolio) added a total of 19 stocks, among them: The most significant addition was Ferguson Enterprises Inc (NYSE:FERG), with 600,000 shares, accounting for 0.26% of the portfolio and a total value of $130.65 million. The second largest addition to the portfolio was Ciena Corp (NYSE:CIEN), consisting of 118,349 shares, representing approximately 0.02% of the portfolio, with a total value of $9,625,330. The third largest addition was FormFactor Inc (NASDAQ:FORM), with 281,444 shares, accounting for 0.02% of the portfolio and a total value of $9,684,490. Key Position Increases First Eagle Investment (Trades, Portfolio) also increased stakes in a total of 153 stocks, among them: The most notable increase was Becton Dickinson & Co (NYSE:BDX), with an additional 3,268,478 shares, bringing the total to 8,786,190 shares. This adjustment represents a significant 59.24% increase in share count, a 1.1% impact on the current portfolio, with a total value of $1,513,421,270. The second largest increase was ONEOK Inc (NYSE:OKE), with an additional 3,545,256 shares, bringing the total to 6,256,173. This adjustment represents a significant 130.78% increase in share count, with a total value of $510,691,400. Summary of Sold Out First Eagle Investment (Trades, Portfolio) completely exited 38 holdings in the second quarter of 2025, as detailed below: Brown & Brown Inc (NYSE:BRO): First Eagle Investment (Trades, Portfolio) sold all 1,921,699 shares, resulting in a -0.5% impact on the portfolio. Invesco Senior Loan ETF (BKLN): First Eagle Investment (Trades, Portfolio) liquidated all 433,094 shares, causing a -0.02% impact on the portfolio. Key Position Reduces First Eagle Investment (Trades, Portfolio) also reduced positions in 202 stocks. The most significant changes include: Reduced Philip Morris International Inc (NYSE:PM) by 1,852,263 shares, resulting in a -20.62% decrease in shares and a -0.61% impact on the portfolio. The stock traded at an average price of $171.52 during the quarter and has returned -3.46% over the past 3 months and 40.87% year-to-date. Reduced Berkshire Hathaway Inc (NYSE:BRK.A) by 263 shares, resulting in a -28.84% reduction in shares and a -0.44% impact on the portfolio. The stock traded at an average price of $762,376 during the quarter and has returned -8.41% over the past 3 months and 3.31% year-to-date. Portfolio Overview At the end of the second quarter of 2025, First Eagle Investment (Trades, Portfolio)'s portfolio included 392 stocks. The top holdings included 4.83% in Meta Platforms Inc (NASDAQ:META), 4.79% in Oracle Corp (NYSE:ORCL), 3.2% in Imperial Oil Ltd (IMO), 3.19% in Wheaton Precious Metals Corp (NYSE:WPM), and 3.17% in HCA Healthcare Inc (NYSE:HCA). The holdings are mainly concentrated in all 11 industries: Basic Materials, Healthcare, Technology, Communication Services, Consumer Defensive, Energy, Financial Services, Industrials, Real Estate, Consumer Cyclical, and Utilities. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data